Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:02 AM
Ignite Modification Date:
2025-12-25 @ 4:02 AM
NCT ID:
NCT05625802
Eligibility Criteria:
Inclusion Criteria:
* Imaging confirmation of urolithiasis on the index encounter or prior encounter within 7 days
* Patient received one dose of parenteral pain medication in the emergency department (ED)
Exclusion Criteria:
* Pregnancy or breastfeeding
* Prisoner or incarcerated individual
* Therapeutic anticoagulation or coagulopathy.
* Active treatment for urinary tract infection (either acute infection or chronic therapy)
* Prior spinal surgery in the thoracic region
* Allergy to local anesthetic or prior local anesthetic
* Soft tissue infection overlying the injection site
* Positive for coronavirus
* Inability to communicate verbally or read/write in English
* Currently taking strong CYP1A2 inhibitor (fluvoxamine, amiodarone, fluoroquinolones, etc.)
* Glucose-6-phosphate dehydrogenase deficiency (G6PD)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05625802
Study Brief:
Protocol Section:
NCT05625802